Pharmaceutical companies

Why pharma doesn't invest in birth control

There hasn't been much innovation in women's birth control since the pill came to market nearly 60 years ago — because drug companies don't stand to make much from it, Bloomberg reports.

Where it stands: Only 2% of drug companies' annual revenue from contraceptives goes back into research and development, according to the Gates Foundation.

Another national security issue: China's drug manufacturing

China’s dominance in drug manufacturing is a national security issue, Bloomberg’s Anna Edney reports.

Details: American officials have expressed two concerns: